Keybanc analyst Adam Josephson initiates coverage on Royal Gold (NASDAQ:RGLD) with a Sector Weight rating.
Kamada Stock Jumps After Acquisition Of Four Plasma-Derived Products
Kamada Ltd (NASDAQ: KMDA) has acquired four FDA-approved plasma-derived hyperimmune commercial products from Saol Therapeutics.